 | • レポートコード：QYR9ST05301 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、虚血性脳卒中薬の世界市場について調査・分析し、虚血性脳卒中薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組織プラスミノーゲン活性化剤、抗凝固薬、抗血小板薬、抗高血圧薬、その他）、用途別（病院、診療所、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の虚血性脳卒中薬市場動向 ・主要企業別マーケットシェア ・虚血性脳卒中薬の種類別市場規模2014-2019 （組織プラスミノーゲン活性化剤、抗凝固薬、抗血小板薬、抗高血圧薬、その他） ・虚血性脳卒中薬の用途別市場規模2014-2019 （病院、診療所、外来手術センター、その他） ・虚血性脳卒中薬の北米市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬の中国市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬の日本国内市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬のインド市場：主要企業・種類別/用途別市場規模 ・虚血性脳卒中薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Merck、Boehringer Ingelheim、Sanofi、Johnson & Johnson、Bayer、Biogen、Abbott Laboratories、Genentech、Daiichi Sankyo） ・虚血性脳卒中薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.
In 2018, the global Ischemic Stroke Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ischemic Stroke Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
Daiichi Sankyo
Market segment by Type, the product can be split into
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Others
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.
To present the Ischemic Stroke Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ischemic Stroke Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ischemic Stroke Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tissue Plasminogen Activator
1.4.3 Anticoagulant
1.4.4 Antiplatelet
1.4.5 Antihypertensive
1.4.6 Others
1.5 Market by Application
1.5.1 Global Ischemic Stroke Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ischemic Stroke Drugs Market Size
2.2 Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Ischemic Stroke Drugs Market Size by Regions (2014-2025)
2.2.2 Ischemic Stroke Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ischemic Stroke Drugs Market Size by Manufacturers
3.1.1 Global Ischemic Stroke Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Ischemic Stroke Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Ischemic Stroke Drugs Key Players Head office and Area Served
3.3 Key Players Ischemic Stroke Drugs Product/Solution/Service
3.4 Date of Enter into Ischemic Stroke Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ischemic Stroke Drugs Market Size by Type (2014-2019)
4.2 Global Ischemic Stroke Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Ischemic Stroke Drugs Market Size (2014-2019)
5.2 Ischemic Stroke Drugs Key Players in United States
5.3 United States Ischemic Stroke Drugs Market Size by Type
5.4 United States Ischemic Stroke Drugs Market Size by Application
6 Europe
6.1 Europe Ischemic Stroke Drugs Market Size (2014-2019)
6.2 Ischemic Stroke Drugs Key Players in Europe
6.3 Europe Ischemic Stroke Drugs Market Size by Type
6.4 Europe Ischemic Stroke Drugs Market Size by Application
7 China
7.1 China Ischemic Stroke Drugs Market Size (2014-2019)
7.2 Ischemic Stroke Drugs Key Players in China
7.3 China Ischemic Stroke Drugs Market Size by Type
7.4 China Ischemic Stroke Drugs Market Size by Application
8 Japan
8.1 Japan Ischemic Stroke Drugs Market Size (2014-2019)
8.2 Ischemic Stroke Drugs Key Players in Japan
8.3 Japan Ischemic Stroke Drugs Market Size by Type
8.4 Japan Ischemic Stroke Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ischemic Stroke Drugs Market Size (2014-2019)
9.2 Ischemic Stroke Drugs Key Players in Southeast Asia
9.3 Southeast Asia Ischemic Stroke Drugs Market Size by Type
9.4 Southeast Asia Ischemic Stroke Drugs Market Size by Application
10 India
10.1 India Ischemic Stroke Drugs Market Size (2014-2019)
10.2 Ischemic Stroke Drugs Key Players in India
10.3 India Ischemic Stroke Drugs Market Size by Type
10.4 India Ischemic Stroke Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Ischemic Stroke Drugs Market Size (2014-2019)
11.2 Ischemic Stroke Drugs Key Players in Central & South America
11.3 Central & South America Ischemic Stroke Drugs Market Size by Type
11.4 Central & South America Ischemic Stroke Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ischemic Stroke Drugs Introduction
12.1.4 Pfizer Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ischemic Stroke Drugs Introduction
12.2.4 Merck Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ischemic Stroke Drugs Introduction
12.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ischemic Stroke Drugs Introduction
12.4.4 Sanofi Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ischemic Stroke Drugs Introduction
12.5.4 Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ischemic Stroke Drugs Introduction
12.6.4 Bayer Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Biogen
12.7.1 Biogen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ischemic Stroke Drugs Introduction
12.7.4 Biogen Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.7.5 Biogen Recent Development
12.8 Abbott Laboratories
12.8.1 Abbott Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ischemic Stroke Drugs Introduction
12.8.4 Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.8.5 Abbott Laboratories Recent Development
12.9 Genentech
12.9.1 Genentech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ischemic Stroke Drugs Introduction
12.9.4 Genentech Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.9.5 Genentech Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Company Details
12.10.2 Company Description and Business Overview
12.10.3 Ischemic Stroke Drugs Introduction
12.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2014-2019)
12.10.5 Daiichi Sankyo Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Ischemic Stroke Drugs Key Market Segments
Table Key Players Ischemic Stroke Drugs Covered
Table Global Ischemic Stroke Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ischemic Stroke Drugs Market Size Market Share by Type 2014-2025
Figure Tissue Plasminogen Activator Figures
Table Key Players of Tissue Plasminogen Activator
Figure Anticoagulant Figures
Table Key Players of Anticoagulant
Figure Antiplatelet Figures
Table Key Players of Antiplatelet
Figure Antihypertensive Figures
Table Key Players of Antihypertensive
Figure Others Figures
Table Key Players of Others
Table Global Ischemic Stroke Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Ischemic Stroke Drugs Report Years Considered
Table Global Ischemic Stroke Drugs Market Size 2014-2025 (Million US$)
Figure Global Ischemic Stroke Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ischemic Stroke Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Ischemic Stroke Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Ischemic Stroke Drugs Market Share by Regions 2014-2019
Figure Global Ischemic Stroke Drugs Market Share by Regions 2014-2019
Figure Global Ischemic Stroke Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Ischemic Stroke Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ischemic Stroke Drugs Market Share by Manufacturers (2014-2019)
Figure Global Ischemic Stroke Drugs Market Share by Manufacturers in 2018
Table Global Ischemic Stroke Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ischemic Stroke Drugs Product/Solution/Service
Table Date of Enter into Ischemic Stroke Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Ischemic Stroke Drugs Market Size Share by Type (2014-2019)
Figure Global Ischemic Stroke Drugs Market Size Market Share by Type (2014-2019)
Table Global Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Ischemic Stroke Drugs Market Size Share by Application (2014-2019)
Figure Global Ischemic Stroke Drugs Market Size Market Share by Application (2014-2019)
Figure Global Ischemic Stroke Drugs Revenue Market Share by Application in 2018
Figure United States Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table United States Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table United States Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure Europe Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table Europe Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table Europe Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure China Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table China Ischemic Stroke Drugs Market Size by Type (2014-20189) (Million US$)
Table China Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table China Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table China Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure Japan Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table Japan Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table Japan Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table Southeast Asia Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table Southeast Asia Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure India Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table India Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table India Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table India Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table India Ischemic Stroke Drugs Market Share by Application (2014-2019)
Figure Central & South America Ischemic Stroke Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ischemic Stroke Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ischemic Stroke Drugs Market Share (2018-2019)
Table Central & South America Ischemic Stroke Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ischemic Stroke Drugs Market Share by Type (2014-2019)
Table Central & South America Ischemic Stroke Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ischemic Stroke Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Ischemic Stroke Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Merck Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bayer Company Details
Table Bayer Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Bayer Recent Development
Table Biogen Company Details
Table Biogen Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Biogen Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Genentech Company Details
Table Genentech Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Genentech Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Ischemic Stroke Drugs Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Ischemic Stroke Drugs Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Global Ischemic Stroke Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Ischemic Stroke Drugs Market Size Share by Regions (2019-2025)
Figure Global Ischemic Stroke Drugs Market Size Share by Regions in 2025
Figure United States Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ischemic Stroke Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Ischemic Stroke Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Ischemic Stroke Drugs Market Size by Product (2019-2025)
Figure Global Ischemic Stroke Drugs Market Size by Product in 2025
Table Global Ischemic Stroke Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Ischemic Stroke Drugs Market Size by Application (2019-2025)
Figure Global Ischemic Stroke Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
虚血性脳卒中薬の世界市場：市場規模・現状・予測 Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.Asia Pacific is anticipated to unfold as the mos…- 急性虚血性脳卒中診断及び治療の世界市場：市場規模・現状・予測 According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases.Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. Heart attacks and …
- 世界のサークル急性虚血性脳卒中市場：専門的調査 The global Circle Acute Ischemic Stroke market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Circle Acute Ischemic Stroke volume and value at global level, regional level and company level. Fro…
- 世界の出血性脳卒中薬市場：専門的調査 For the appropriate management of hemorrhagic stroke treatment, an adequate understanding of diagnostic modalities and parenchymal hemorrhagic is crucial. There are advanced diagnostic facilities and diagnostic modalities that not only help neurologists in hemorrhagic stroke treatment to identify th…
- 虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…